BC
CLX icon

Bridgefront Capital’s Clorox CLX Stock Holding History

Bridgefront Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-32,222
Closed -$3.34M – 550
2026
Q1 		$3.34M Buy
+32,222
New +$3.65M 0.83% 7
2025
Q4 		– Sell
-4,070
Closed -$502K – 563
2025
Q3 		$502K Sell
4,070
-9,302
-70% -$1.15M 0.15% 247
2025
Q2 		$1.61M Buy
13,372
+6,394
+92% +$853K 0.43% 37
2025
Q1 		$1.03M Buy
6,978
+1,537
+28% +$235K 0.3% 80
2024
Q4 		$884K Buy
+5,441
New +$890K 0.3% 81
2024
Q3 		– Sell
-8,502
Closed -$1.16M – 553
2024
Q2 		$1.16M Buy
8,502
+6,825
+407% +$948K 0.48% 34
2024
Q1 		$257K Sell
1,677
-783
-32% -$117K 0.2% 239
2023
Q4 		$351K Buy
+2,460
New +$328K 0.26% 141
2022
Q4 		– Sell
-2,536
Closed -$326K – 385
2022
Q3 		$326K Buy
+2,536
New +$366K 0.33% 115
2022
Q1 		– Sell
-2,777
Closed -$484K – 295
2021
Q4 		$484K Buy
+2,777
New +$463K 0.47% 55
2021
Q3 		– Sell
-5,311
Closed -$956K – 388
2021
Q2 		$956K Buy
+5,311
New +$969K 0.36% 55

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bridgefront Capital's CLX Position: Q2 2026 in Review

Bridgefront Capital sold out of Clorox (CLX) in Q2 2026, closing a stake of 32,222 shares — an estimated $3.34M sold.

Bridgefront Capital first reported a position in CLX in Q2 2021 and held it in 11 quarters. The position peaked at $3.34M in Q1 2026. 1,055 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Bridgefront Capital reported no remaining Clorox position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 32,222 Clorox shares in Q2 2026, an estimated $3.34M.
  • Bridgefront Capital first reported a position in Clorox in Q2 2021 and held it in 11 quarters.
  • Bridgefront Capital's Clorox position peaked at $3.34M in Q1 2026.
  • 1,055 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.